This inventor holds 1 USPTO granted patent. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,268 
1 out of 3,075 
Years Active: 2022
Title: Haoxuan Tong: Innovator in Cancer Therapy Biomarkers
Introduction
Haoxuan Tong is a prominent inventor based in Cambridge, MA, specializing in the field of cancer research. He has made significant contributions to the understanding of cancer therapies through his innovative work on biomarkers.
Latest Patents
Haoxuan Tong holds a patent titled "P13K-MTORC1-S6K1 signaling pathway biomarkers predictive of anti-cancer responses." This invention focuses on the identification of novel biomarkers that predict responsiveness to anti-cancer therapies, which can potentially enhance treatment outcomes for patients.
Career Highlights
Throughout his career, Haoxuan Tong has worked with esteemed institutions such as the Dana-Farber Cancer Institute and Harvard College. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Thomas M. Roberts and Jean Zhao, who have also made significant contributions to cancer research.
Conclusion
Haoxuan Tong's innovative work in identifying biomarkers for cancer therapy showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his patent reflects the potential for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile